VIR-2482 (Dose 1) for Flu

"Yes, the information on clinicaltrials.gov suggests that this trial is actively recruiting participants. The trial was initially posted on 10/30/2022 and was most recently edited on 11/15/2022. The clinical trial is looking for 3000 participants at 48 sites."

"This influenza clinical trial, which is currently enrolling 3000 participants that are between 18-64 years old, requires patients to be in good health and have no significant findings from their medical history, physical examination, 12-lead electrocardiogram (ECG), vital signs, and laboratory values."

"Right now, this clinical trial is enrolling patients from 48 different sites. Some of these locations include San Diego, Aurora and Jupiter. There are also other places that you can choose from to try and minimize travel if you decide to participate in the study."

"According to the eligibility requirements set out by the researchers, patients between 18 and 64 years old may apply to participate in this trial. There are 39 other trials for minors and 76 for seniors."

"Our analysts have given VIR-2482 (Dose 1) a rating of 2 in terms of safety. This is due to the lack of efficacy data, as this is only a Phase 2 trial."

"The trial is recruiting patients at this time, as of 11/15/2022. This information can be found on clinicaltrials.gov, where the trial was first posted on 10/30/2022."